Delivery Order SPE2DB22D2007-SPE2DB25FJ3KH
- Not listed
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of M-M-R II vaccine vials, with a ceiling value of $4,185.90. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $4,685.90 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of M-M-R II vaccine vials. The contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.76 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for M-M-R II vaccine vials with a ceiling value of $2,351.28. This firm fixed-price delivery order, which is expected to be completed by August 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA...
- The Defense Logistics Agency awarded a $2,351.28 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for M-M-R II vaccine vials, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, without a set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,175.66 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $7,136.69 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order, awarded on August 1, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilized no set-aside designation and was competitively awarded through an open procurement process. This delivery order is a child contract...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3KHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for M-M-R II vaccine vials with a ceiling value of $126,439.10. This firm fixed-price delivery order, which is a non-set-aside competitive award, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical vendor for federal medical procurement and has demonstrated substantial capability in fulfilling DLA requirements through open competition. The company's federal contract portfolio encompasses a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for M-M-R II vaccines reflects the company's role in supporting military medical supply chain operations and immunization requirements across the department of defense enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $126.4k | 7/29/25 |